Learn more about the exciting field of intratumoral immunotherapy and OncoSec’s role as a key leader in this emerging space.
Watch the Video
OncoSec Provides Highlights from Research Reception at AACR Annual Meeting 2018
OncoSec to Host Research Reception During the 2018 American Association of Cancer Research Annual Meeting
OncoSec Announces Strategic Relocation Of Office And Laboratories
OncoSec To Present At The Oppenheimer’s 28th Annual Healthcare Conference
Our core technology platform continues to advance through clinical trials for various cancers.
The ImmunoPulse® platform is designed to boost the immune system to recognize and attack tumors.
OncoSec continues to establish relationships with industry leaders to further advance our research.
PDF | 2.0 MB
PDF | 1.0 MB